Presentation is loading. Please wait.

Presentation is loading. Please wait.

Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy  Darren J.

Similar presentations


Presentation on theme: "Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy  Darren J."— Presentation transcript:

1 Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy  Darren J. Bryk, Elton Llukani, William C. Huang, Herbert Lepor  The Journal of Urology  Volume 194, Issue 5, Pages (November 2015) DOI: /j.juro Copyright © 2015 American Urological Association Education and Research, Inc. Terms and Conditions

2 Figure 1 Improvement of CSR from baseline to followup mpMRI. On baseline mpMRI T2-weighted image note geographic low signal in posteromedial peripheral zone apex, crossing midline (A), and corresponding low ADC on ADC map (B). On followup mpMRI note normal signal on T2-weighted image (C) and normal ADC in region of original CSR (D). Posterior midline area of decreased signal at this level was attributed to pseudolesion24 in this region. The Journal of Urology  , DOI: ( /j.juro ) Copyright © 2015 American Urological Association Education and Research, Inc. Terms and Conditions

3 Figure 2 Stable CSR from baseline to followup mpMRI. On baseline mpMRI T2-weighted image note crescentic region of decreased signal in left posterolateral peripheral zone base to mid gland (A) and corresponding low ADC on ADC map (B). On followup mpMRI T2-weighted image crescentic hypointensity remains (C) and ADC map is stable with low ADC (D). The Journal of Urology  , DOI: ( /j.juro ) Copyright © 2015 American Urological Association Education and Research, Inc. Terms and Conditions


Download ppt "Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy  Darren J."

Similar presentations


Ads by Google